Thermo Fisher Scientific has come up with a portfolio of equally strong Absolute Q dPCR assays. This makes use of the Company’s several years of experience, special assay design algorithms ...
Thermo Fisher Scientific has introduced over 50 new Absolute Q Liquid Biopsy Assays to run on the Applied Biosystems QuantStudio Absolute Q dPCR System. Never miss a story ...
Eve Burstein, an analyst from Bernstein, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated price target was ...
Michael Ryskin, an analyst from Bank of America Securities, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated ...
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per share was 2.7% above analysts’ consensus ...